Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study

Objective To estimate the strength of association between exposure to selected classes of prescribed medications and the risk of developing iron deficiency anaemia (IDA), specifically considering oral anticoagulants (OACs), antidepressants, antiplatelet agents, proton pump inhibitors (PPIs) and non-...

Full description

Saved in:
Bibliographic Details
Main Authors: Orouba Almilaji, Jonathon Snook, Kiran Prabhu, Elizabeth Williams, Frazer Warricker
Format: Article
Language:English
Published: BMJ Publishing Group 2024-06-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/11/1/e001305.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856515636789248
author Orouba Almilaji
Jonathon Snook
Kiran Prabhu
Elizabeth Williams
Frazer Warricker
author_facet Orouba Almilaji
Jonathon Snook
Kiran Prabhu
Elizabeth Williams
Frazer Warricker
author_sort Orouba Almilaji
collection DOAJ
description Objective To estimate the strength of association between exposure to selected classes of prescribed medications and the risk of developing iron deficiency anaemia (IDA), specifically considering oral anticoagulants (OACs), antidepressants, antiplatelet agents, proton pump inhibitors (PPIs) and non-steroidal anti-inflammatories.Design A case–control study involving the analysis of community repeat prescriptions among subjects referred with IDA, and unmatched controls referred as gastroenterology fast-tracks for other indications. Multivariable logistic regression modelling was used to calculate ORs for the association between IDA presentation and each medication class, adjusted for age, sex and coprescribing. For those classes showing significance, it was also used to calculate risk differences between those in the IDA group with or without haemorrhagic lesions on investigation.Results A total of 1210 cases were analysed—409 in the IDA group, and 801 in the control group. Significant associations were identified between presentation with IDA and long-term exposure to PPIs (OR 3.29, 95% CI: 2.47 to 4.41, p<0.001) and to OACs (OR 2.04, 95% CI: 1.29 to 3.24, p=0.002). IDA was not associated with long-term exposure to any of the other three drug classes. In contrast to the relationship with PPIs, the association with OACs was primarily in the IDA sub-group with haemorrhagic lesions.Conclusion Long-term exposure to PPIs and OACs are independently associated with the risk of developing IDA. There are grounds for considering that these associations may be causal, though the underlying mechanisms probably differ.
format Article
id doaj-art-9587bea603f8420b9687787d22afba61
institution Kabale University
issn 2054-4774
language English
publishDate 2024-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-9587bea603f8420b9687787d22afba612025-02-12T08:10:10ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742024-06-0111110.1136/bmjgast-2023-001305Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control studyOrouba Almilaji0Jonathon Snook1Kiran Prabhu2Elizabeth Williams3Frazer Warricker4Department of Health Service Research and Policy, London School of Hygiene & Tropical Medicine, London, UKPoole Hospital NHS Foundation Trust, Poole, UKPoole Hospital NHS Foundation Trust, Poole, UKPoole Hospital NHS Foundation Trust, Poole, UKPoole Hospital NHS Foundation Trust, Poole, UKObjective To estimate the strength of association between exposure to selected classes of prescribed medications and the risk of developing iron deficiency anaemia (IDA), specifically considering oral anticoagulants (OACs), antidepressants, antiplatelet agents, proton pump inhibitors (PPIs) and non-steroidal anti-inflammatories.Design A case–control study involving the analysis of community repeat prescriptions among subjects referred with IDA, and unmatched controls referred as gastroenterology fast-tracks for other indications. Multivariable logistic regression modelling was used to calculate ORs for the association between IDA presentation and each medication class, adjusted for age, sex and coprescribing. For those classes showing significance, it was also used to calculate risk differences between those in the IDA group with or without haemorrhagic lesions on investigation.Results A total of 1210 cases were analysed—409 in the IDA group, and 801 in the control group. Significant associations were identified between presentation with IDA and long-term exposure to PPIs (OR 3.29, 95% CI: 2.47 to 4.41, p<0.001) and to OACs (OR 2.04, 95% CI: 1.29 to 3.24, p=0.002). IDA was not associated with long-term exposure to any of the other three drug classes. In contrast to the relationship with PPIs, the association with OACs was primarily in the IDA sub-group with haemorrhagic lesions.Conclusion Long-term exposure to PPIs and OACs are independently associated with the risk of developing IDA. There are grounds for considering that these associations may be causal, though the underlying mechanisms probably differ.https://bmjopengastro.bmj.com/content/11/1/e001305.full
spellingShingle Orouba Almilaji
Jonathon Snook
Kiran Prabhu
Elizabeth Williams
Frazer Warricker
Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
BMJ Open Gastroenterology
title Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
title_full Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
title_fullStr Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
title_full_unstemmed Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
title_short Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
title_sort role of prescribed medication in the development of iron deficiency anaemia in adults a case control study
url https://bmjopengastro.bmj.com/content/11/1/e001305.full
work_keys_str_mv AT oroubaalmilaji roleofprescribedmedicationinthedevelopmentofirondeficiencyanaemiainadultsacasecontrolstudy
AT jonathonsnook roleofprescribedmedicationinthedevelopmentofirondeficiencyanaemiainadultsacasecontrolstudy
AT kiranprabhu roleofprescribedmedicationinthedevelopmentofirondeficiencyanaemiainadultsacasecontrolstudy
AT elizabethwilliams roleofprescribedmedicationinthedevelopmentofirondeficiencyanaemiainadultsacasecontrolstudy
AT frazerwarricker roleofprescribedmedicationinthedevelopmentofirondeficiencyanaemiainadultsacasecontrolstudy